FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057454 [Registered on: 12/09/2023] Trial Registered Prospectively
Last Modified On: 11/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Comparison of movable perimetry with non-movable perimetry among subjects with or without any eye disease 
Scientific Title of Study   Comparison of Portable Perimetry with Standard Automated Perimetry among subjects with and without any ocular disease 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ramesh S Ve 
Designation  Professor, Department of Optometry 
Affiliation  Manipal College of Health Professions 
Address  Department of Optometry,3rd floor Room No 313 Manipal College of Health Professions

Udupi
KARNATAKA
576104
India 
Phone  8861330950  
Fax    
Email  ramesh.sve@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Deeksha Nayak 
Designation  Post Graduate Student  
Affiliation  Manipal College of Health Professions  
Address  Department of Optometry, 3rd floor Room No 313, Manipal College of Health Professions

Udupi
KARNATAKA
576104
India 
Phone  8088620223  
Fax    
Email  deeksha2.mchpmpl2022@learner.manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Neetha KIR  
Designation  Associate Professor 
Affiliation  Kasturba Medical College 
Address  Department of Ophthalmology,2nd floor, Room No 25,Kasturba Hospital Manipal

Udupi
KARNATAKA
576104
India 
Phone  9886161979  
Fax    
Email  neetha.kir@manipal.edu  
 
Source of Monetary or Material Support  
Manipal College of Health Professions (MCHP),Manipal Academy of Higher Education (MAHE),Manipal-576104,Karnatka,India 
 
Primary Sponsor  
Name  Dr Ramesh S Ve 
Address  Department of Optometry, 3rd floor,Room No- 313,Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal-576104,Karnataka,India 
Type of Sponsor  Other [Self Sponsor] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ramesh S Ve  Kasturba Hospital   Department of Opthalmology,2nd floor, Consultation room no 26 Udupi KARNATAKA
Udupi
KARNATAKA 
8861330950

ramesh.sve@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H408||Other glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  Cases
Eye with worse visual field defect
Early to advanced glaucoma (cupping of optic nerve damage, SAP reports indicating visual field defects
Pseudophakic after 1 month
Retinal diseases include Retinopathy, Retinitis Pigmentosa, ARMD, Vascular retinopathy etc.

Normal
Aged between 18 - 85 years
Diagnosed healthy eyes
Best Corrected Visual Acuity (BCVA) of 0.1 log MAR or better
The refractive error between ±6.00 DS equivalent & cylindrical correction within ± 3.00 DC

 
 
ExclusionCriteria 
Details  Cases
Visually significant cataract (based on lens opacities classification)
Recent cataract surgery (1 month)
History of retinal surgery
Unable to perform perimetry
Visual acuity less than 6/60
Corneal dystrophy, trauma
History of having epilepsy or any other neurological disorders

Normal
Any ocular pathology other than cataract
Systemic diseases affecting visual function
Under any medication that affects vision


 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reliability indices, Global indices and individual sensitivity, threshold values and variability.  Reliability indices, Global indices and individual sensitivity, threshold values and variability at Baseline (15-20 minutes) 
 
Secondary Outcome  
Outcome  TimePoints 
Not applicable  Not applicable 
 
Target Sample Size   Total Sample Size="245"
Sample Size from India="245" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The research will be initiated after the approval from the Institution Research Committee (IRC) following the Institutional Ethics Committee (IEC) and then approval from the university. The participants will be recruited & written informed consent will be taken. They will then undergo routine eye examination (if they didn’t have any past one month) with the standard or the widely used measure for the detailed history taking, vision assessment, refraction, extraocular motility test, intraocular pressure measurement, anterior segment examination, posterior segment examination. An additional set of standard tests required to confirm the eligibility criteria for the normal subjects (if they didn’t have any past 1 month) is perimetry and for glaucoma & retinal subjects (if they didn’t have any past 1 month) are perimetry.

After this set of procedures, those who are fulfilling the eligibility criteria will be given an appointment based on his/her and the examiner’s feasibility.

In Phase I and Phase II, the patients will be recruited from the eye OPD only. Controls are the participants who will have no clinically significant retinal conditions like Glaucoma and Vascular retinopathies. Mainly patients who will be coming for the general eye examination for glasses one month after the cataract surgery will be included in the study.

 
Close